Visualise is an innovative consensus-driven programme that was developed to deliver practical and relevant hands-on examples and discussion of decision making for disease control. The Visualise programme launched in 2019 and the content is ratified by expert consensus and opinion.

The aim of the Visualise programme is to:

  • help up-skill healthcare professionals in order to improve effective diagnosis, management and treatment of nAMD and its clinical complications
  • provide access to expert opinions and discussions
  • provide case studies that represent practical and relevant real-life examples of patient management strategies for disease control

Please contact your local MSL for more information on Visualise.


Visualise on-demand webinar

Watch a video by an international speaker from the United States, Professor Srinivas Sadda, entitled Optimising our use of OCT for management of neovascular AMD. Professor Sadda covers the nuances concerning how imaging technologies are used in the management of nAMD patients. He touches upon the diagnostic standpoint, as well as decision making when it comes to the treatment and retreatment of patients.




AMD, age-related macular degeneration; nAMD, neovascular age-related macular degeneration; OCT, optical coherence tomography.

Rate this content: 
No votes yet
BEO20-C039s November 2020.

Ask Speakers


Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]